Transcatheter treatment of pure aortic regurgitation

Competing interests

M.B. is consultant for Boston Scientific, Edwards Lifesciences and Medtronic. F.M. declares grant or research institutional support from Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, NVT, Terumo and Venus; has received consulting fees and honoraria (both personal and institutional) from Abbott, Cardiovalve, Edwards Lifesciences, Medtronic, Mtex, Occlufit, Simulands, Squadra, Valgen, Venus and Xeltis; has received royalty income from Edwards Lifesciences; and is shareholder (including share options) of 4Tech, Magenta and Transseptalsolutions. G.L. declares no competing interests.

留言 (0)

沒有登入
gif